[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-359140-105":59,"doc-detail-359140-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","ai-driven-nanomedicine-for-cancer-theranostics","AI-driven nanomedicine for cancer theranostics","","Nanomedicine integrated with artificial intelligence is transforming cancer theranostics by enabling the precise design of multifunctional nanoparticles that can both diagnose and treat disease. The review contrasts shortcomings of conventional therapies—imprecise delivery, systemic toxicity, and delayed recognition—with theranostic nanoplatforms that support targeted drug transport and live imaging. It surveys clinical relevance across liposomes, gold nanoparticles, iron oxide nanoparticles, and quantum dots, and reviews AI approaches used for prediction, synthesis optimization, biodistribution modeling, and inverse design.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ai-driven-nanomedicine-for-cancer-theranostics/359140/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ai-driven-nanomedicine-for-cancer-theranostics/359140.png","ImageObject",300,407,{"name":92,"@type":93},"Ophelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",15,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What problem does AI-driven nanomedicine aim to solve in cancer theranostics?","Question",{"text":113,"@type":114},"It targets imprecise delivery, general body toxicity, and late-stage disease recognition by designing multifunctional nanoparticles that can diagnose and treat while enabling more precise delivery and live imaging.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which theranostic nanomaterial classes are emphasized as clinically significant?",{"text":118,"@type":114},"The review focuses on liposomes, gold nanoparticles, iron oxide nanoparticles, and quantum dots.",{"name":120,"@type":111,"acceptedAnswer":121},"What major challenges are discussed for AI applications in this field?",{"text":122,"@type":114},"Key difficulties include nanotoxicity, AI explainability, data limitations, and regulatory concerns, alongside ethical dilemmas.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},359140,1790194422,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":29,"preview_urls":147},7971461741311,"https://ap-avatar.wpscdn.com/avatar/74000253aff267980c6?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779345379180704826","Tiwari et al. Molecular Cancer (2026) 25:78 [https://doi.org/10.1186/s12943-025-02563-9](https://doi.org/10.1186/s12943-025-02563-9)  \nMolecular Cancer  \nREVIEW Open Access  \nAI-driven nanomedicine for cancer theranostics  \nAshutosh Tiwari1, Widodo2, Dyah Ika Krisnawati3,4, Chih-Yu Chen 1,5,6* and Tsung-Rong Kuo 1,7,8*  \nAbstract  \nNanomedicine's merging with artificial intelligence (AI) is fundamentally changing cancer theranostics through precise creation of multifunctional nanoparticles which can simultaneously diagnose and treat diseases. Traditional cancer treatments today face issues with imprecise delivery and general body toxicity as well as late-stage disease recognition which theranostic nanoplatforms address through precision drug transport and live imaging functions. In this analysis, we examine the existing state and forthcoming developments of AI applications in cancer theranostics through nanoparticles. Our study first examines the three primary classes of theranostic nanomaterials that show clinical significance: liposomes, gold nanoparticles, iron oxide nanoparticles, and quantum dots. AI is being applied to nanoparticle development through machine learning, deep learning, reinforcement learning, and generative models that support physicochemical predictions, synthesis optimization, biodistribution modeling, and inverse design. We analyze clinical applications of AI solutions which support patient identification, response predictions, and implementation of virtual patient models for individualized cancer treatment. The paper evaluates major difficulties which are nanotoxicity, AI explainability, data limitations, and regulatory concerns while addressing ethical dilemmas. Rather than a broad overview of nanomedicine, we center on AI methods that directly improve theranostic decisions and support this with worked exemplars reporting datasets, baselines, metrics, and clinical tie-ins. This Task–Data–Method–Metric lens replaces generic background and grounds claims in reproducible evidence.  \nKeywords AI-driven nanomedicine, Cancer theranostics, Smart nanoparticle, Inverse design, Precision oncology, Nanotoxicity  \nIntroduction: rethinking cancer management atthe nanoscale  \nCancer imposes a severe strain on global healthcare systems with about 10 million annual deaths recorded in 2020 and future projections of a 60% increase in the incidence during the next 20 years [1]. Existing systemic  \n*Correspondence:  \nChih-Yu Chen [aleckc2424@tmu.edu.tw](aleckc2424@tmu.edu.tw)[ ](aleckc2424@tmu.edu.tw)Tsung-Rong Kuo [trkuo@tmu.edu.tw](trkuo@tmu.edu.tw)  \nFull list of author information is available at the end of the article  \nchemotherapy and radiotherapy as well as immunotherapy treatments have experienced significant advancements, but overall survival outcomes for most solid tumors have remained poor in cases of advanced-stage diagnoses, because current treatments produce limited and non-specific benefits [2, 3]. Cancer control fails most often at the point where biology outpaces our timing. Intratumoral heterogeneity, rapid evolutionary escape, and spatially diverse tumor niches mean that the same patient can host multiple disease states, some sensitive, others already resistant. Conventional pathways still deliver average therapies to changing tumors, and diagnostic signals arrive too slowly to prevent overtreatment  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative C","cbCaiuTkqwQswHbO","https://ap.wps.com/l/cbCaiuTkqwQswHbO","pdf",11099418,55,"English","# Abstract\n# Introduction: rethinking cancer management atthe nanoscale\n# Graphical abstract\n# Limitations of conventional therapies and role of nanomedicine\n# AI methods for theranostic decision support","[{\"question\":\"What problem does AI-driven nanomedicine aim to solve in cancer theranostics?\",\"answer\":\"It targets imprecise delivery, general body toxicity, and late-stage disease recognition by designing multifunctional nanoparticles that can diagnose and treat while enabling more precise delivery and live imaging.\"},{\"question\":\"Which theranostic nanomaterial classes are emphasized as clinically significant?\",\"answer\":\"The review focuses on liposomes, gold nanoparticles, iron oxide nanoparticles, and quantum dots.\"},{\"question\":\"What major challenges are discussed for AI applications in this field?\",\"answer\":\"Key difficulties include nanotoxicity, AI explainability, data limitations, and regulatory concerns, alongside ethical dilemmas.\"}]","AI-driven nanomedicine for cancer theranostics | PDF",1790136226,139,[148,152,156,160,164,168],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e144c1e23aa4f052a78de4bd2fd3a283.webp",983,1310,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/94e68909694eda253f22914db42c1160.webp",982,1309,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b3187003c2200f09df98676d9f4d0568.webp",981,1308,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9242abcfe23099f4c7cf13069fb8c4c9.webp",980,1306,{"page_no":24,"url":165,"width":166,"height":167},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1fc04e8aeef19861feabe53db617ed7d.webp",979,1305,{"page_no":29,"url":169,"width":170,"height":171},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d723b9264b72a47ed2cab15aac80de25.webp",978,1304]